Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2021 Aug 12;16(8):e0255986. doi: 10.1371/journal.pone.0255986

Stockpiled personal protective equipment and knowledge of pandemic plans as predictors of perceived pandemic preparedness among German general practitioners

Arno Stöcker 1,*, Ibrahim Demirer 1, Sophie Gunkel 1, Jan Hoffmann 1, Laura Mause 1, Tim Ohnhäuser 1, Nadine Scholten 1
Editor: Jianguo Wang2
PMCID: PMC8360569  PMID: 34383827

Abstract

Background

The COVID-19 pandemic significantly changed the work of general practitioners (GPs). At the onset of the pandemic in March 2020, German outpatient practices had to adapt quickly. Pandemic preparedness (PP) of GPs may play a vital role in their management of a pandemic.

Objectives

The study aimed to examine the association in the stock of seven personal protective equipment (PPE) items and knowledge of pandemic plans on perceived PP among GPs.

Methods

Three multivariable linear regression models were developed based on an online cross-sectional survey for the period March–April 2020 (the onset of the pandemic in Germany). Data were collected using self-developed items on self-assessed PP and knowledge of a pandemic plan and its utility. The stock of seven PPE items was queried. For PPE items, three different PPE scores were compared. Control variables for all models were gender and age.

Results

In total, 508 GPs were included in the study; 65.16% believed that they were very poorly or poorly prepared. Furthermore, 13.83% of GPs were aware of a pandemic plan; 40% rated those plans as beneficial. The stock of FFP-2/3 masks, protective suits, face shields, safety glasses, and medical face masks were mostly considered completely insufficient or insufficient, whereas disposable gloves and disinfectants were considered sufficient or completely sufficient. The stock of PPE was significantly positively associated with PP and had the largest effect on PP; the association of the knowledge of a pandemic plan was significant but small. PPE scores did not vary considerably in their explanatory power. The assessment of a pandemic plan as beneficial did not significantly affect PP.

Conclusion

The stock of PPE seems to be the determining factor for PP among German GPs; for COVID-19, sufficient masks are the determining factor. Knowledge of a pandemic plans play a secondary role in PP.

Introduction

The coronavirus disease 2019 (COVID-19) pandemic took Germany and many other countries by surprise in 2020. Within a few weeks, social and work life changed. The healthcare sector was one of the most affected areas [13]. Pandemic plans were activated [4], and emergency measures were taken in hospitals and intensive care units to treat a large number of patients with COVID-19 [5]. However, general practitioners (GPs) are often the first to have contact with potential patients with COVID-19 [3,6] and the majority of patients with COVID-19 –mostly with mild and moderate symptoms [7,8]–are treated in GP practices. Apart from the additional workload of treating patients with COVID-19, GPs have to maintain regular primary health care [2,3,9,10]. General practitioners have been facing multiple challenges during the COVID-19 pandemic, such as a high risk of being infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) themselves [11], including the risk of mortality [12] and psychological impacts with regard to work and personal life [13]. Overall, pandemic preparedness (PP) is an important factor in being better able to manage the challenges of a pandemic [14,15].

At the beginning of the COVID-19 pandemic, many personal protective equipment (PPE) items were in short supply in Germany and worldwide [16,17], both for private use [18] and in the healthcare sector [19,20]. Specifically, medical masks and FFP-2/3 masks were in high demand and short supply [20]. As Germany has a federated and self-governing system in the healthcare sector with 17 self-regulatory regional organization for the outpatient sector, clear division of responsibilities was often absent [21]. Many physicians complained about a general, long-lasting shortage of PPE [22,23].

Prior to the outbreak of the COVID-19 pandemic, a variety of pandemic plans existed in Germany [24]. For example, the Robert Koch Institute, a German federal government agency responsible for disease control and prevention, established a national influenza pandemic plan (last update 2016/2017) [25]. On March 4, 2020, a supplement to the national pandemic plan regarding COVID-19 was published [26]. On March 13, 2020, the national pandemic plan has been activated [27]. In addition, the Kassenärztliche Bundesvereingung (German Association of Statutory Health Insurance Physicians) had published a document regarding influenza pandemic "Risk Management in Medical Practices" in 2008, which is specifically aimed at the outpatient sector [28]. Furthermore, each of the 16 German states has its own pandemic plan, and several cities have also established their own pandemic plans [24,29]. In the event of an influenza pandemic, German pandemic plans ensure priority of outpatient treatment [24].

While the necessity of sufficient knowledge [30] and adequate PPE in general [79] have been recognized for protecting health care professionals and maintaining the operation of medical facilities during a pandemic, different PPE items have been considered and compared less often. Therefore, in this study, we aim to further investigate how stocked PPE items effect perceived PP. In addition to adequate PPE, pandemic plans are considered a firm cornerstone with regard to PP in the healthcare sector [31,32]. However, the effect of pandemic plans on GPs’ personal PP has not been studied to our knowledge; other studies are limited to polling knowledge of pandemic plans and their utility [8]. Hence, in this study we investigated how the stock of seven PPE items and knowledge of a pandemic plan are associated with PP among German GPs.

Method

Design

This analysis is part of the research project “The COVID-19 crisis and its impact on the German ambulatory sector–the physicians’ view” (COVID-GAMS). The study is based on an anonymous, online cross-sectional survey that is conducted at three different points in time in 2020 and 2021. The first survey was conducted in June–September 2020 retrospectively for the period March–April 2020, which corresponded with the peak of the first COVID-19 wave in Germany. During questionnaire conception and development, preliminary interviews were conducted with different representatives of the listed group of specialists. The questionnaire was subsequently tested by several physicians from different specialty groups who were not involved in the design. The questions relevant to this study can be accessed in German and English in the appendix (S1 Table).

Participants and recruitment

A total of 18,000 outpatient physicians were invited to participate in the online survey: GPs (6,500), dentists (4,000), gynecologists (2,000), pediatricians (2,000), otolaryngologists (2,000), cardiologists (1,000), and gastroenterologists (500). The study population was selected to capture outpatient care during the Corona pandemic from the perspective of different medical disciplines. The address data for the random study sample was selected in collaboration with the National Association of Statutory Health Insurance Physicians. Invitations were sent by fax and e-mail, followed by three reminders at 2-week intervals. In addition, physicians were invited to participate in the survey via the project homepage (www.covid-gams.de) and various specialist associations. In this analysis, we examine only responses of GPs. The survey (including invitation letter, study and privacy information and questionnaire) was approved by the Ethics Committee of the University of Cologne (20–1169_1). The online survey was conducted anonymously, without directly collecting personal identifying information, so that only implicit consent had to be obtained in accordance with the ethics vote of the Ethics Committee of the University Hospital of Cologne. The terms and conditions of the study had to be agreed to in order to participate in the study. Participation in the survey could be terminated at any time. The possibility to pause the survey and continue it later was technically possible. Participation was voluntary for all participants. No expense allowance or payment was paid for participation.

Measures

The focus of the analysis, examined as the dependent variable, was the following research question: “How prepared did you feel at your practice for a pandemic in early March?” Answers were given on a 5-point Likert scale (1 = very bad, 2 = bad, 3 = moderate, 4 = good, 5 = very good) and processed as numerical outcomes [33]. The first predictor was stockpiled PPE (FFP-2/3 masks, medical face masks, disposable gloves, hand and surface disinfectants, safety glasses, protective suits, and face shields). The following answers could be given for the question “As of early March, what was your inventory of the following protective and hygienic materials?”: not relevant, completely inadequate (1), inadequate (2), adequate (3), completely adequate (4). Responses with "not relevant" were excluded for further analysis. The second predictor of interest was knowledge of an epidemic or pandemic plan (yes/no). General practitioners who reported having knowledge of a pandemic plan were further asked whether those plans helped them manage during the COVID-19 pandemic (yes/no). On the basis of these responses, two binary-coded variables were developed (no = 0, yes = 1). Age (in 10-year increments) and gender of the participating GPs were included as control variables in each regression model. Gender has been found to affect PP in some studies in the past [34,35]. Early in the COVID-19 pandemic, there was strong evidence that advanced age has an effect on disease progression [36] and, hence, older GPs may have felt generally less prepared for the pandemic. Therefore, it was reasonable to include both variables in the model to control for any confounding effects. Because the study population of GPs was otherwise rather homogeneous, we refrained from including additional control variables.

Statistical analysis

Three groups of multivariate regression models were used to examine the factors affecting perceived PP. In the first set of models, three different PPE scores were compared. We assumed that there is an underlying interplay between relevant PPE items, hence, different PPE scores were computed. If an essential PPE item is missing, the protection chain may be interrupted, so that even items that are actually sufficiently on hand cannot develop their full protective effect. Therefore, it seemed appropriate to combine PPE items into PPE scores. Three types of PPE scores were obtained: 1. a general PPE score with all PPE items combined, 2. an exploratively investigated optimized PPE score with those PPE items that showed a significant association with PP, and 3. a masks-only score with the two PPE mask types (FFP-2/-3 and medical masks) as masks provide the greatest protection against SARS-CoV-2 infection. For each type of score, the numeric responses given to each included PPE item were summed and divided by the number of PPE items. Thus, each PPE score ranges between 1 and 4. The optimized PPE score is an exploratory compiled value used to compare the goodness of the models with the general PPE and the masks score. In the second regression model, the association of knowledge of a pandemic plan on PP was examined. In addition, a potential interaction effect between knowledge of a pandemic plan and stocked PPE on perceived PP was explored. Knowledge of a pandemic plan may have an interaction effect with stocked PPE, as more PPE maybe stored if a pandemic plan is known or higher PP can be reported with the same level of stockpiled PPE if a pandemic plan is known. The third model investigated whether a pandemic plan rated as beneficial was associated with perceived PP. Again, a potential interaction effect between a pandemic plan viewed as beneficial and PPE in storage was included in the model to test interactions similar to those described in model 2. Data preparation (tidyverse package [1.3.0]) and analysis (lessR package [3.9.9] and psych package [2.0.12]) were performed in R (version 4.03) and R Studio (version 1.3.1093).

Results

Sample

In total, 1,703 physicians participated in the first survey, including 535 GPs. Of these, 508 GPs responded to the relevant item on PP. In total, 265 male, 242 female, and one non-binary GP participated (Table 1); of these, 11.05% were 31–40 years old, 25.44% were 41–50 years old, 40.83% were 51–60 years old, and 22.68% were older than 60 years.

Table 1. General practitioners’ (n = 508) characteristics and pandemic preparedness, personal protective equipment, and knowledge on a pandemic plan and its utility.

Variables n (%)
Pandemic preparedness (n = 508)
        very poor 134 (26.38)
        poor 197 (38.78)
        partly 132 (26.98)
        good 34 (6.67)
        very good 11 (2.17)
        missings -
FFP-2/3 Masks (n = 507)
        not relevant 4 (0.79)
        completely insufficient 315 (62.13)
        insufficient 125 (24.65)
        sufficient 52 (10.26)
        completely sufficient 11 (2.17)
        missings 1
Mouth and nose protection (n = 508)
        not relevant 1 (0.20)
        completely insufficient 118 (23.23)
        insufficient 214 (42.13)
        sufficient 141 (27.76)
        completely sufficient 34 (6.69)
        missings -
Disposable gloves (n = 508)
        not relevant -
        completely insufficient 12 (2.36)
        insufficient 61 (12.01)
        sufficient 305 (60.04)
        completely sufficient 130 (25.59)
        missings -
Hand and surface disinfectants (n = 508)
        not relevant -
        completely insufficient 22 (4.33)
        insufficient 105 (20.67)
        sufficient 276 (54.33)
        completely sufficient 105 (20.67)
        missings -
Safety glasses (n = 508)
        not relevant 9 (1.77)
        completely insufficient 253 (49.80)
        insufficient 128 (25.20)
        sufficient 95 (18.70)
        completely sufficient 23 (4.53)
        missings
Protective suits (n = 508)
        not relevant 9 (1.77)
        completely insufficient 305 (60.04)
        insufficient 130 (25.59)
        sufficient 52 (10.24)
        completely sufficient 12 (2.36)
        missings
Face shields (n = 507)
        not relevant 57 (11.24)
        completely insufficient 331 (65.29)
        insufficient 81 (15.98)
        sufficient 30 (5.92)
        completely sufficient 8 (1.58)
        missings 1
Prior knowledge of any pandemic plan (n = 506)
        no 436 (86.17)
        yes 70 (13.83)
        missings 2
if yes:
Helpfulness of pandemic plan (n = 70)
        no 42 (60.00)
        yes 28 (40.00)
missings -
Age (n = 507)
        30 years and younger -
        31 to 40 years 56 (11.05)
        41 to 50 years 129 (25.44)
        51 to 60 years 207 (40.83)
        older than 60 years 115 (22.68)
missings 1
Gender (n = 508)
        male 265 (52.16)
        female 242 (47.64)
        none-binary 1 (0.00)
missings -

Nearly two-thirds of GPs believed that they and their practice were poorly or very poorly prepared for a pandemic; only 8.84% reported that they were well or very well prepared. In terms of PPE stock, GPs reported that FFP-2/3 masks (89.78%), protective suits (85.63%), face shields (81.27%), safety glasses (75.00%), and medical face masks (65.36%), respectively, were completely insufficient or insufficient, whereas GPs reported that disposable gloves (85.63%) and hand and surface disinfectants (75.00%) were sufficient or completely sufficient at the beginning of March 2020. Cronbach’s alpha for the seven PPE items was .81 (CI: .78; .83). There was no collinearity between different PPE items as no individual variance inflation factors did exceed 2 (Table 2). A high number of GPs (86.17%) had no knowledge of a pandemic plan; of the 70 GPs who had knowledge of such a plan, a slight majority (60%) rated such plans as not beneficial for the SARS-CoV-2 pandemic.

Table 2. Collinearity: Variance inflation factor and tolerance for personal protective equipment items.

VIF Tolerance
FFP-2/3 masks 1.750 .571
medical masks 1.500 .667
surgical gloves 1.917 .522
hand and surface disinfectants 1.939 .516
safety glasses 1.739 .575
protective suits 1.990 .503
face shields 1.553 .644

Multivariable linear regression models

Individuals with no information on age or gender or categories with less than three individuals per group were excluded from further investigation for statistical reasons (n = 2). In total, three groups of multivariate linear regression models were examined. The first model group examined the association of PPE and different PPE scores with PP. The second examined knowledge of a pandemic plan, and the third explored estimates of the utility of known pandemic plans on PP.

In the first set of linear regressions (Table 3), we examined PPE more closely. In the first linear regression model, the association between a general PPE score and PP was measured with age and gender as control variables. The PPE score showed to be a significant coefficient with a positive, non-standardized effect of 1.011 on PP; the adjusted R2 value was .348. In the second model, a masks-only score was calculated on the basis of only the two mask types (FFP-2/3 and medical masks). The masks-only score explained the variance in the data analogously to the general PPE score in the first model (adj. R2 = .349), with a significant association of .797 (p < .001). All PPE items were included individually in the third model (Table 3). Because 61 physicians did not provide information on all PPE items, only 445 responses from GPs were included into this model. The model with the individual materials showed an adjusted R2 of .359. FFP-2/3 masks (coef. = .263), medical masks (coef. = .252), protective suits (coef. = .229), and face shields (coef. = .207) had a significant positive effect on PP. On the basis of these exploratory findings, an optimized PPE score was generated in model 4 (Table 3), with the four significant PPE items. This score was found to explain the observed variances slightly better (adj. R2 = .379) than the general PPE score or the masks-only score, with a significant effect of .928 (p < .001). In the first two models (general PPE score and masks-only score), the control variable age >60 was significantly negatively associated with PP.

Table 3. Multivariable linear regression model on personal protective equipment and pandemic preparedness among general practitioners.

Model I (General PPE score) Model II (Masks score) Model III (individual PPE materials) Model IV (optimized PPE score)
Parameter Estimate [95% conf. interval] Std. error P-value Estimate [95% conf. interval] Std. error P-value Estimate [95% conf. interval] Std. error P-value Estimate [95% conf. interval] Std. error P-value
Intercept .227 [-.109; .563] .171 .185 .913 [.636; 1.190] .141 < .001 .472 [.057; .887] .211 .026 .785 [.509; 1.060] .140 < .001
Independent variables
FFP-2/3 masks .263 [.136; .390] .065 < .001
medical face masks .252 [.147; .354] .053 < .001
disposable gloves .058 [-.083; .200] .072 .419
hand and surface disinfectants .077 [-.051; .204] .065 .238
safety glasses -.048 [-.151; .055] .052 .356
protective suits .229 [.096; .363] .068 .001
face shields .207 [.081; .333] .064 .001
PPE-Score 1.011 [.889; 1.133] .062 < .001
PPE-Score optimized .928 [.822; 1.033] .053 < .001
Masks-Score .797 [.701; .894] .049 < .001
Control variables
Age
41 to 50 years -.140 [-.388; .108] .126 .267 -.128 [-.374; .118] .125 .308 -.161 [-.407; .084] .125 .198 -.116 [-.356; .124] .122 .343
51 to 60 years -.141 [-.376; .094] .120 .238 -.195 [-.428; .039] .119 .102 -.207 [-.438; .023] .117 .078 -.127 [-.355; .101] .116 .273
older than 60 years -.185 [-.438; .067] .128 .150 -.258 [-.509; -.007] .128 .044 -.262 [-.514; -.010] .128 .041 -.192 [-.437; .054] .125 .125
Gender
female -.010 [-.152; .132] .072 .887 -.066 [-.206; .075] .072 .360 -.046 [-.191; .099] .074 .537 -.066 [-.203; .072] .070 .348
Number of obs. 506 505 445 505
R2 .355 .355 .375 .385
Adj. R2 .348 .349 .359 .379
F-stats 54.986 54.994 23.623 62.568
df 500 499 433 499
p-value < .001 < .001 < .001 < .001

The next set of models (Table 4) examined the effect of knowledge of a pandemic plan on perceived PP. The first linear regression model (Table 4) included the variable regarding knowledge of a pandemic plan (no = 0, yes = 1) and the two control variables age and gender. A significant positive association of .521 with PP was found; however, the model quality was low, with an adjusted R2 of .037. Adding the general PPE score containing all PPE items to the model (model 2, Table 4) improved the explained variance, with an adjusted R2 value of .359. Both PPE score (coef. = .987) and knowledge of a pandemic plan (coef. = .300) are significantly positively associated with perceived PP. Similar results were observed when using the masks-only score (model 3, Table 4) as well as the optimized PPE score (model 4, Table 4). In addition, the covariance factor for age >60 showed significant associations with PP in the model with the masks-only score. The final variable included in the model was an interaction term between the general PPE score and knowledge on a pandemic plan (model 5, Table 4). The interaction term showed no association with perceived PP. Likewise, there was no significant interaction effect observed in the other two models with the other two PPE scores. These two models are not presented here.

Table 4. Multivariable linear regression model on knowledge of a pandemic plan and pandemic preparedness among general practitioners.

Model I (Knowledge on plan) Model II (Knowledge on plan + PPE score) Model III (Knowledge on plan + masks score) Modell IV (Knowledge on plan + optimized PPE score) Model V (Knowledge on plan:PPE score)
Parameter Estimate [95% conf. interval] Std. error P-value Estimate [95% conf. interval] Std. error P-value Estimate [95% conf. interval] Std. error P-value Estimate [95% conf. interval] Std. error P-value Estimate [95% conf. interval] Std. error P-value
Intercept 2.309 [2.046; 2.571] .134 < .001 .240 [-.094; .574] .170 .158 .895 [.620; 1.170] .140 < .001 .780 [.507; 1.054] .139 < .001 .341 [.014; .696] .180 .059
Independent variables
Prior knowledge of pandemic plan .521 [.278; .764] .124 < .001 .300 [.100; .500] .102 .003 .333 [.135; .532] .101 .001 .274 [.079; .469] .099 .006 -.265 [-.971; .442] .360 .462
PPE score .987 [.865; 1.109] .062 < .001 .936 [.800; 1.073] .069 < .001
PPE score optimized .909 [.804; 1.015] .054 < .001
Mask score .783 [.687; .879] .049 < .001
Knowledge:PPE score .253 [-.050; .555] .154 .102
Control variables
Age
41 to 50 years -.050 [-.351; .252] .153 .746 -.147 [-.393; .099] .125 .242 -.136 [-.380; .108] .124 .273 -.123 [-.361; .116] .121 .313 -.139 [-.385; .107] .125 .266
51 to 60 years -.150 [-.436; .136] .146 .304 -.141 [-.375; .093] .119 .236 -.191 [-.423; .040] .118 .105 -.128 [-.355; .099] .115 .268 -.140 [-.373; .093] .119 .239
older than 60 years -.304 [-.611; .003] .156 .052 -.200 [-.450; .051] .128 .119 -270 [-.518; -.021] .127 .034 -.203 [-.446; .041] .124 .103 -.194 [-.445; .056] .127 .129
Gender
female -.088 [-.260; .085] .088 .319 -.010 [-.151; .131] .072 .893 -.060 [-.200; .079] .071 .397 -.063 [-.200; .073] .070 .363 -.010 [-.151; .131] .072 .891
Number of obs. 504 504 503 503 504
R2 .046 .367 .369 .395 .370
Adj. R2 .037 .359 .362 .388 .361
F-stats 4.843 47.968 48.409 54.085 41.638
df 498 497 496 496 496
p-value < .001 < .001 < .001 < .001 < .001

In the final group of models (Table 5), we considered only those GPs who reported being aware of a pandemic plan prior to the outbreak of the COVID-19 pandemic. These 70 GPs were asked whether they considered the known pandemic plan beneficial in managing the COVID-19 pandemic. The first regression model (model 1, Table 5) showed that the assessment of the pandemic plan as beneficial controlled for the two variables age and gender was not significantly associated with perceived PP. In the next model (model 2, Table 5), the PPE score was added. With the addition of the PPE score, the explanation of variance increased to an adjusted R2 of .546; again, the PPE score itself showed a significant positive association with PP (1.195), but an assessment of the utility of the pandemic plan did not. In the final regression model (model 3, Table 5), an interaction term was formed between the assessment of the pandemic plan as beneficial and the PPE score. Assessing the pandemic plan as beneficial did not significantly interact with the PPE score on perceived PP (p = .052). The model indicated a good fit, with an adjusted R2 of .566. Models with the other two scores did not show such close significance values. These two models are not presented here.

Table 5. Multivariable linear regression model of assessment of pandemic plan as beneficial and pandemic preparedness among general practitioners.

Model I (Plan helpful) Model II (Plan helpful + PPE-Score) Model III (Plan helpful + PPE-Score + Plan helpful:PPE-Score)
Parameter Estimate [95% conf. interval] Std. error P-value Estimate [95% conf. interval] Std. error P-value Estimate [95% conf. interval] Std. error P-value
Intercept 2.717 [1.830; 3.603] .444 < .001 -.207 [-1.079; .665] .436 .637 -.668 [-1.639; .304] .486 .174
Independent variables
Pandemic plan helpful .348 [-.196; .892] .272 .206 .300 [-.062; .661] .181 . 102 1.476 [.236; 2.715] .620 .020
PPE score 1.195 [.932; .459] .132 < .001 1.404 [1.071; 1.737] .166 < .001
Pandemic plan helpful:PPE-Score -.515 [-1.035; .005] .260 .052
Control variables
Age
41 to 50 years -.090 [-1.067; .887] .489 .854 .038 [-.611; .687] .325 .907 .023 [-.611; .658] .318 .941
51 to 60 years -.032 [-.991; .927] .480 .947 .030 [-.606; .666] .319 .925 .026 [-.596; .649] .311 .933
older than 60 years -.262 [-1.245; .721] .492 .597 .100 [-.557; .758] .329 .761 .118 [-.525; .761] .322 .716
Gender
female -.237 [-.792; .318] .278 .396 -.100 [-.470; .269] .185 .590 -.124 [-.486; .238] .181 .495
Number of obs. 504 70 70 70
R2 .042 .585 .610
Adj. R2 -.032 .546 .566
F-stats .566 14.805 13.837
df 64 63 62
p-value .725 < .001 < .001

Discussion

The aim of this study was to determine the association of stockpiled PPE and knowledge of pandemic plans on the PP of German GPs. It has been shown that the stock of PPE is the most important factor for PP. Different PPE scores differed only to a small extent in the variance explained. Knowledge of a pandemic plan also showed to be significantly associated with PP, but the association was much smaller in comparison with PPE. Assessment of the utility of a known pandemic plan showed no significant association with PP.

Numerous studies on the effect of the COVID-19 pandemic on the outpatient sector report low levels of PP in Germany [37] and in several other countries [8,38], with only a few exceptions [10]. The significance of availability and access to PPE for pandemic management was frequently observed during the COVID-19 pandemic [7,8] and during other pandemics [39]. However, many studies do not specifically address the particular inventory of different PPE items [37]. Our results suggest that for reasons of simplicity and data minimization, it seems appropriate to focus on the stock of FFP-2/3 and medical masks in regard to PP in the context of the COVID-19 pandemic. The insignificant changes in the explained variance of the different PPE scores point in this direction. Because SARS-COV-2 is transmitted via the respiratory tract, this focus seems theoretical plausible as well. However, comparability between the different PPE scores and the model with individual PPE items is somewhat limited by missing individual values for different items. In particular, face shields were not considered relevant by 57 GPs. This high number of assessments of face shields as irrelevant contradicts to some extent the results of our model, where a significant positive association between face shields and PP was identified. Also other studies have shown that eye and face protection are important factors [40]. The significant positive association of protective suits cannot be classified in the category of protection of eyes and face. Because the survey referred to the beginning of the pandemic in Germany in March–April 2020, this may can be interpreted as the effect of a great uncertainty among the GPs, who demanded complete protection on the face of great uncertainty.

The calculation of the mean value of the PPE scores was chosen in order to consider possible interactions between different PPE items. However, the results between the models with PPE scores and the model with the individual PPE items did not show large differences for the different approaches. Thus, an actual interaction between different PPE items has not been confirmed beyond doubt. It can also be argued that a simple average of PPE items does not adequately represent the interaction. It may would be conceivable to weight lower inventories to a greater extent. Different PPE items are needed for optimal protection, so the lack of just one item may make sufficient stocks in all other items inadequate.

Physicians face unique challenges in times of pandemics; therefore, a well-structured and widely known pandemic plan is believed to help establish effective strategies in advance [8]. However, we found that the majority of GPs considered a pandemic plan not beneficial regarding the COVID-19 pandemic and that the assessment of a plan as beneficial did not show a significant effect on PP, whereas pre-existing knowledge of such a plan had a small positive effect on PP, which indicates that the specific content of the pandemic plan is somewhat less relevant. If engagement with a pandemic plan helps to address general and cross-pandemic processes in advance, it may create an overall pandemic awareness that can be adapted to individual challenges of a particular pandemic. Knowledge on a pandemic plan could than serve as proxy for pandemic awareness. Nevertheless, the variance explained by this predictor was rather small. However, the knowledge of a pandemic plan may also have an opposite effect of decreasing the perceived PP because the knowledge of such plans makes GPs aware of what they have to consider and how great their deficits truly are. Furthermore, other influencing factors of PP not examined here, include profound knowledge about the disease and the manner in which that knowledge is disseminated [41] and proper use of PPE [39], fear of transmitting the infection to families and loved ones [39], compliance of healthcare workers with proper infection prevention [42], emotional support [43], and years of experience, and training in infection control [44].

The interaction term examining the relationship between the assessment of the pandemic plan as beneficial and the stockpile of PPE items in model 3 in Table 4 showed a non-significant association between the assessment of a pandemic plan as beneficial and the PPE score that was just slightly above the threshold for significance at .05 (p = .052). Because only 70 GPs were even aware of a pandemic plan, this association should be further investigated. Our findings give rise to the hypothesis that when a pandemic plan is considered beneficial, the quantity of PPE items is not quite as crucial as without this assessment. Knowledge of a beneficial pandemic plan would than enhance the effect on perceived PP when the PPE items is in low supply, but when sufficient PPE are available, the positive effect of PPE on PP is no longer quite as large.

Limitations

As the cross-sectional online survey was conducted in the early stages of the COVID-19 pandemic in Germany, the study may have certain limitations. First, the survey was conducted in June–September 2020 retrospectively for the period March–April 2020. Therefore, the possibility that evaluations and assessments were ex post distorted between the observation and survey period cannot be eliminated, especially in the case of a dynamic event such as a pandemic. The survey period was chosen in order to consider the different summer school holidays in the German federal states. Second, although the sample was chosen for representative purposes, selection bias may have occurred owing to the low response rate and the distribution of the survey via the project homepage and the different specialist societies, which makes it challenging to draw conclusions about all German GPs. The low response rate may be explained by GPs’ increased workload and uncertainty during a pandemic. Because PP among German GPs was generally rated as poor and this is a cross-sectional study, it is not clear whether there is a true causal relationship between stockpiled PPE and perceived PP. Moreover, the results on individual PPE items may have limited applicability to other pandemic scenarios as each pandemic presents different challenges to physicians and the infection and transmission pathways differ between pandemics. With regard to the provision of disinfectants, the inventory of hand and surface disinfectants was queried together. Accordingly, this survey cannot provide more precise information on the distinction between the two PPE materials.

Because this is an anonymous survey, it cannot be ruled out that participants may have responded to the survey more than once or that non-physicians participated. Though, at the beginning of the survey, it was asked whether the participant works as a physician in the outpatient sector. If this answer was negative, participation in the survey was terminated. Nevertheless, it cannot be ruled out that deliberately false statements were made here. The selected recruitment method does not allow representative conclusions for GPs in Germany. However, if we consider key sociodemographic characteristics of the study participants (S2 Table) and compare them with the basic population of German GPs, it becomes clear that there are indications that the study population represents German GPs reasonably accurately. First of all, participants from all 16 German federal states and city states took part in the study. In view of the statistical data from the German Federal Register of Physicians, it appears that our study population was, on average, somewhat younger than the average German GPs (approximately 53 years compared to 55.4 years) [45]. With regard to the gender distribution of the sample, this corresponds to the national average for GPs (52% male, 48% female) provided by the Federal Register of Physicians [46]. About 90% of the physicians surveyed reported that they are self-employed. This is about 10 percentage points higher than the national average according to data from the 2020 physician statistics of the German Medical Association [47]. The overrepresentation of self-employed physicians can possibly be explained by the fact that they were contacted via fax. Although the invitation letters were personalized, the faxes may nevertheless have been presented to the practice owner. Also, in the case of practice email addresses, the practice owner may have been the primary contact or may have had access first. It is also possible that self-employed physicians have a higher level of commitment and identification with their own profession, so that a slight selection bias cannot be ruled out. Furthermore, a possible selections bias may also have implications for the reported PP. More job committed individuals may also have higher general preparedness. As a result, this could lead to a slight overestimation of the pandemic preparedness of the analyses in the population.

Conclusion

In Germany, a large proportion of GPs believed that they were poorly or very poorly prepared for a pandemic at the beginning of the COVID-19 pandemic; however, high PP among GPs can play a vital role in ensuring that the healthcare sector as a whole is better prepared for future pandemics. Pandemic preparedness can be explained in large part by the possession of sufficient PPE. Possession of FFP-2/3 masks, medical masks, protective suits, and face shields are significantly positively associated with PP. The findings of the study justify focusing on the stock of medical and FFP 2/3 masks among PPE. Overall, only 14% of GPs had knowledge about a pandemic plan. A multivariate linear regression analysis showed that knowledge of a pandemic plan is significantly associated to a small positive extent with perceived PP among German GPs. However, the positive association of PPE significantly exceeded that of knowledge of a pandemic plan. Whether the known pandemic plan was rated as beneficial or not showed no effect on addressing the challenges associated with COVID-19. The PP of German GPs thus depends largely on the stockpile of PPE; pandemic plans play a rather subordinate role.

Supporting information

S1 Table. Questionnaire (German and English translation) questionnaire (German, original version).

(DOCX)

S2 Table. Key sociodemographic characteristics.

(DOCX)

Acknowledgments

The authors express their gratitude to all participating physicians. Despite the fact that they remain anonymous, this study would not have been possible without their participation.

Data Availability

The authors have uploaded a minimal data set to Data Archiving and Networked Services (DANS) which is available at https://doi.org/10.17026/dans-z7a-b6p9.

Funding Statement

This work is associated with the research project “COVID GAMS” (https://www.covid-gams.de) funded by the German Federal Ministry of Education and Research (BMBF 01KI2099, https://www.bmbf.de/bmbf/en/). NS received a grant from which AS is partly paid. The funding source had no role in the design, conduct, or reporting of this study; or in the decision to submit the manuscript for publication.

References

  • 1.Provenzano DA, Sitzman BT, Florentino SA, Buterbaugh GA. Clinical and economic strategies in outpatient medical care during the COVID-19 pandemic. Reg Anesth Pain Med. 2020; 45:579–85. Epub 2020/05/31. doi: 10.1136/rapm-2020-101640 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Ali MK, Shah DJ, Del Rio C. Preparing Primary Care for COVID-20. J Gen Intern Med. 2020. Epub 2020/06/09. doi: 10.1007/s11606-020-05945-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Zewudie A, Regasa T, Kebede O, Abebe L, Feyissa D, Ejata F, et al. Healthcare Professionals’ Willingness and Preparedness to Work During COVID-19 in Selected Hospitals of Southwest Ethiopia. Risk Manag Healthc Policy. 2021; 14:391–404. Epub 2021/02/03. doi: 10.2147/RMHP.S289343 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Holthof N, Luedi MM. Considerations for acute care staffing during a pandemic. Best Pract Res Clin Anaesthesiol. 2020. doi: 10.1016/j.bpa.2020.12.008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Tartari E, Hopman J, Allegranzi B, Gao B, Widmer A, Cheng VC-C, et al. Perceived challenges of COVID-19 infection prevention and control preparedness: A multinational survey. J Glob Antimicrob Resist. 2020; 22:779–81. Epub 2020/07/11. doi: 10.1016/j.jgar.2020.07.002 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Huston P, Campbell J, Russell G, Goodyear-Smith F, Phillips RL, van Weel C, et al. COVID-19 and primary care in six countries. BJGP Open. 2020; 4. Epub 2020/10/27. doi: 10.3399/bjgpopen20X101128. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Fiorino G, Colombo M, Natale C, Azzolini E, Lagioia M, Danese S. Clinician Education and Adoption of Preventive Measures for COVID-19: A Survey of a Convenience Sample of General Practitioners in Lombardy, Italy. Ann Intern Med. 2020; 173:405–7. Epub 2020/04/15. doi: 10.7326/M20-1447 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Sotomayor-Castillo C, Nahidi S, Li C, Hespe C, Burns PL, Shaban RZ. General practitioners’ knowledge, preparedness, and experiences of managing COVID-19 in Australia. Infect Dis Health. 2021. doi: 10.1016/j.idh.2021.01.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Lee JQ, Loke W, Ng QX. The Role of Family Physicians in a Pandemic: A Blueprint. Healthcare (Basel). 2020; 8. Epub 2020/07/05. doi: 10.3390/healthcare8030198. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Lau J, Tan DH-Y, Wong GJ, Lew Y-J, Chua Y-X, Low L-L, et al. The impact of COVID-19 on private and public primary care physicians: A cross-sectional study. J Infect Public Health. 2021; 14:285–9. doi: 10.1016/j.jiph.2020.12.028 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Verhoeven V, Tsakitzidis G, Philips H, van Royen P. Impact of the COVID-19 pandemic on the core functions of primary care: will the cure be worse than the disease? A qualitative interview study in Flemish GPs. BMJ Open. 2020; 10:e039674. Epub 2020/06/17. doi: 10.1136/bmjopen-2020-039674. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Campbell RG. SARS-CoV-2 and the nose: Risks and implications for primary care. Aust J Gen Pract. 2020; 49:728–32. doi: 10.31128/AJGP-05-20-5452 . [DOI] [PubMed] [Google Scholar]
  • 13.Feingold JH, Peccoralo L, Chan CC, Kaplan CA, Kaye-Kauderer H, Charney D, et al. Psychological Impact of the COVID-19 Pandemic on Frontline Health Care Workers During the Pandemic Surge in New York City. Chronic Stress (Thousand Oaks). 2021; 5:2470547020977891. Epub 2021/02/01. doi: 10.1177/2470547020977891. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Fineberg HV. Pandemic preparedness and response—lessons from the H1N1 influenza of 2009. N Engl J Med. 2014; 370:1335–42. doi: 10.1056/NEJMra1208802 . [DOI] [PubMed] [Google Scholar]
  • 15.Riegel AC, Chou H, Baker J, Antone J, Potters L, Cao Y. Development and execution of a pandemic preparedness plan: Therapeutic medical physics and radiation dosimetry during the COVID-19 crisis. J Appl Clin Med Phys. 2020; 21:259–65. Epub 2020/07/11. doi: 10.1002/acm2.12971 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Cohen J, van der Rodgers YM. Contributing factors to personal protective equipment shortages during the COVID-19 pandemic. Prev Med. 2020; 141:106263. Epub 2020/10/02. doi: 10.1016/j.ypmed.2020.106263. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Hoernke K, Djellouli N, Andrews L, Lewis-Jackson S, Manby L, Martin S, et al. Frontline healthcare workers’ experiences with personal protective equipment during the COVID-19 pandemic in the UK: a rapid qualitative appraisal. BMJ Open. 2021; 11:e046199. Epub 2021/01/20. doi: 10.1136/bmjopen-2020-046199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Gierthmuehlen M, Kuhlenkoetter B, Parpaley Y, Gierthmuehlen S, Köhler D, Dellweg D. Evaluation and discussion of handmade face-masks and commercial diving-equipment as personal protection in pandemic scenarios. PLoS One. 2020; 15:e0237899. Epub 2020/08/19. doi: 10.1371/journal.pone.0237899. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Widmer AF, Richner G. Proposal for a EN 149 acceptable reprocessing method for FFP2 respirators in times of severe shortage. Antimicrob Resist Infect Control. 2020; 9:88. Epub 2020/06/17. doi: 10.1186/s13756-020-00744-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Boškoski I, Gallo C, Wallace MB, Costamagna G. COVID-19 pandemic and personal protective equipment shortage: protective efficacy comparing masks and scientific methods for respirator reuse. Gastrointest Endosc. 2020; 92:519–23. Epub 2020/04/27. doi: 10.1016/j.gie.2020.04.048 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Buthe T, Messerschmidt L, Cheng C. Policy Responses to the Coronavirus in Germany. SSRN Journal. 2020. doi: 10.2139/ssrn.3614794 [DOI] [Google Scholar]
  • 22.Wernhart S, Förster T-H, Weihe E. Outpatient Management of Oligosymptomatic Patients with respiratory infection in the era of SARS-CoV-2: Experience from rural German general practitioners. BMC Infect Dis. 2020; 20:811. Epub 2020/11/06. doi: 10.1186/s12879-020-05538-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Pult H. COVID-19 Pandemic: Survey of future use of personal protective equipment in optometric practice. Cont Lens Anterior Eye. 2020; 43:208–10. Epub 2020/04/22. doi: 10.1016/j.clae.2020.04.006 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Lange H-J, Gusy C, editors. Kooperation im Katastrophen- und Bevölkerungsschutz. Wiesbaden: Springer VS; 2015. [Google Scholar]
  • 25.Robert-Koch-Institut. Nationaler Pandemieplan Teil I. Robert Koch-Institut; 2017.
  • 26.Robert-Koch-Institut. Ergänzung zum Nationalen Pandemieplan–COVID-19 –neuartige Coronaviruserkrankung. 2020 [cited 1 Apr 2021]. Available from: https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Ergaenzung_Pandemieplan_Covid.html.
  • 27.König S, Ueberham L, Pellissier V, Hohenstein S, Meier-Hellmann A, Thiele H, et al. Hospitalization deficit of in- and outpatient cases with cardiovascular diseases and utilization of cardiological interventions during the COVID-19 pandemic: Insights from the German-wide helios hospital network. Clin Cardiol. 2021; 44:392–400. Epub 2021/01/26. doi: 10.1002/clc.23549 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Frosch H, Knöpnadel J, Liebeskind U, Lisiak B, Remé T, Schmidt W, et al. Influenzapandemie–Risikomanagement in Arztpraxen. Eine Empfehlung der Kassenärztlichen Bundesvereinigung, der Bundesärztekammer und der BGW. Heiligenhafen: Eggers Druckerei & Verlag GmbH; 2008. [Google Scholar]
  • 29.Piwernetz K, Neugebauer E. COVID-19-Pandemie als Weckruf für einen Strategiewechsel. NeuroTransmitter. 2020; 31:16–25. doi: 10.1007/s15016-020-7523-9 [DOI] [Google Scholar]
  • 30.Temsah MH, Alhuzaimi AN, Alamro N, Alrabiaah A, Al-Sohime F, Alhasan K, et al. Knowledge, attitudes and practices of healthcare workers during the early COVID-19 pandemic in a main, academic tertiary care centre in Saudi Arabia. Epidemiol Infect. 2020; 148:e203. Epub 2020/08/28. doi: 10.1017/S0950268820001958. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Azziz-Baumgartner E, Smith N, González-Alvarez R, Daves S, Layton M, Linares N, et al. National pandemic influenza preparedness planning. Influenza Other Respir Viruses. 2009; 3:189–96. doi: 10.1111/j.1750-2659.2009.00091.x . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Tomizuka T, Kanatani Y, Kawahara K. Insufficient preparedness of primary care practices for pandemic influenza and the effect of a preparedness plan in Japan: a prefecture-wide cross-sectional study. BMC Fam Pract. 2013; 14:174. Epub 2013/11/19. doi: 10.1186/1471-2296-14-174. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Carifio J, Perla RJ. Ten Common Misunderstandings, Misconceptions, Persistent Myths and Urban Legends about Likert Scales and Likert Response Formats and their Antidotes. J of Social Sciences. 2007; 3:106–16. doi: 10.3844/jssp.2007.106.116 [DOI] [Google Scholar]
  • 34.Dickinson JA, Bani-Adam G, Williamson T, Berzins S, Pearce C, Ricketson L, et al. Alberta family physicians’ willingness to work during an influenza pandemic: a cross-sectional study. Asia Pac Fam Med. 2013; 12:3. Epub 2013/06/26. doi: 10.1186/1447-056X-12-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Aoyagi Y, Beck CR, Dingwall R, Nguyen-Van-Tam JS. Healthcare workers’ willingness to work during an influenza pandemic: a systematic review and meta-analysis. Influenza Other Respir Viruses. 2015; 9:120–30. doi: 10.1111/irv.12310 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Promislow DEL. A Geroscience Perspective on COVID-19 Mortality. J Gerontol A Biol Sci Med Sci. 2020; 75:e30–e33. doi: 10.1093/gerona/glaa094 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Siebenhofer A, Huter S, Avian A, Mergenthal K, Schaffler-Schaden D, Spary-Kainz U, et al. COVI-Prim survey: Challenges for Austrian and German general practitioners during initial phase of COVID-19. PLOS ONE. 2021; 16:e0251736. Epub 2021/06/10. doi: 10.1371/journal.pone.0251736. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Al-Ashwal FY, Kubas M, Zawiah M, Bitar AN, Mukred Saeed R, Sulaiman SAS, et al. Healthcare workers’ knowledge, preparedness, counselling practices, and perceived barriers to confront COVID-19: A cross-sectional study from a war-torn country, Yemen. PLoS One. 2020; 15:e0243962. Epub 2020/12/11. doi: 10.1371/journal.pone.0243962. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Fogel I, David O, Balik CH, Eisenkraft A, Poles L, Shental O, et al. The association between self-perceived proficiency of personal protective equipment and objective performance: An observational study during a bioterrorism simulation drill. Am J Infect Control. 2017; 45:1238–42. Epub 2017/06/30. doi: 10.1016/j.ajic.2017.05.018 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Jefferson T, Jones MA, Al-Ansary L, Bawazeer GA, Beller EM, Clark J, et al. Physical interventions to interrupt or reduce the spread of respiratory viruses. Part 1—Face masks, eye protection and person distancing: systematic review and meta-analysis.; 2020. doi: 10.1002/14651858.CD006207.pub5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Uyaroğlu OA, Başaran NÇ, Ozisik L, Karahan S, Tanriover MD, Guven GS, et al. Evaluation of the effect of COVID-19 pandemic on anxiety severity of physicians working in the internal medicine department of a tertiary care hospital: a cross-sectional survey. Intern Med J. 2020; 50:1350–8. Epub 2020/10/02. doi: 10.1111/imj.14981 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Temsah M-H, Al-Sohime F, Alamro N, Al-Eyadhy A, Al-Hasan K, Jamal A, et al. The psychological impact of COVID-19 pandemic on health care workers in a MERS-CoV endemic country. J Infect Public Health. 2020; 13:877–82. Epub 2020/05/29. doi: 10.1016/j.jiph.2020.05.021 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Kurotschka PK, Serafini A, Demontis M, Serafini A, Mereu A, Moro MF, et al. General Practitioners’ Experiences During the First Phase of the COVID-19 Pandemic in Italy: A Critical Incident Technique Study. Front Public Health. 2021; 9:623904. Epub 2021/02/03. doi: 10.3389/fpubh.2021.623904. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Dalky HF, Ghader N, Al Kuwari M, Alnajar M, Ismaile S, Almalik M, et al. Assessment of the Awareness, Perception, Attitudes, and Preparedness of Health-care Professionals Potentially Exposed to COVID-19 in the United Arab Emirates. J Multidiscip Healthc. 2021; 14:91–102. Epub 2021/01/15. doi: 10.2147/JMDH.S278479 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.German Federal Registry of Physicians (Kassenärztliche Bundesvereinigung). Anzahl Ärzte/Psychotherapeuten nach Alter (Number of physicians/psychotherapists by age). 2011–2020. Kassenärztliche Bundesvereinigung (KBV) [cited 24 Jul 2021]. Available from: https://gesundheitsdaten.kbv.de/cms/html/16397.php.
  • 46.German Federal Registry of Physicians (Kassenärztliche Bundesvereinigung). Anzahl Ärzte/Psychotherapeuten nach Geschlecht (Number of physicians/psychotherapists by gender). 2011–2020 [cited 24 Jul 2021]. Available from: https://gesundheitsdaten.kbv.de/cms/html/16396.php.
  • 47.German Medical Association (Bundesärztekammer). Ärztestatistik zum 31. Dezember 2020 (Physician statistics per December 31, 2020). Berlin; 08.04.2021.

Decision Letter 0

Jianguo Wang

11 Jun 2021

PONE-D-21-13972

Stockpiled personal protective equipment and knowledge of pandemic plans as predictors of perceived pandemic preparedness among German general practitioners

PLOS ONE

Dear Dr. Stöcker,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

  • Please submit your revised manuscript by Jul 26 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

    Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Jianguo Wang, PhD

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please include additional information regarding the survey or questionnaire used in the study and ensure that you have provided sufficient details that others could replicate the analyses. For instance, if you developed a questionnaire as part of this study and it is not under a copyright more restrictive than CC-BY, please include a copy, in both the original language and English, as Supporting Information.

Furthermore, in your Methods section, please provide a justification for the sample size used in your study, including any relevant power calculations (if applicable).

3. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified (1) whether consent was suitably informed and (2) what type you obtained (for instance, written or verbal). If your study included minors under age 18, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information.

4. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide.

5. Please include a copy of Table 5 which you refer to in your text on page 15.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Thank you for the chance to review this manuscript. I thought that this was generally a well-written manuscript focusing on the association between sufficiency of various PPE stocks and perceived pandemic preparedness among German GPs.

The authors found that PPE stocks in general seem to be significant associated with PP scores, and that facial protection in particular was a prominent piece of PPE. Both of these findings seem logical to me given the understanding of the COVID-19 situation and known transmission mechanics at the time that the study was conducted.

I also felt that the authors used appropriate regression analyses that were well detailed in the Results section, and the Discussion was able to present an interpretation without overclaiming the validity of the findings.

I just have two minor comments for the authors to improve their manuscript for potential publication:

1. I understand from your Methods section that 6,500 GPs were invited to participate, of which 535 GPs responded. This is a very low response rate of approximately 8.2%.

How might this low response rate have affected the generalisability of your study's findings? Given that your survey was online and anonymous, would it have been possible for certain selection biases (e.g., location, socio-economic status) to affect the findings? Is there a possibility of data errors (e.g., same GP responding to the survey more than once)?

If there is insufficient data (due to anonymity of the respondents) to establish the presence of these biases, it would be good to elaborate on them in the limitations section.

2. On line 121, you mention that the study population of GPs was relatively homogeneous as a way of justifying why only age and gender were chosen as potential confounders. It would be ideal for you to demonstrate to the reader that this homogeneity in your study sample is actually true. For example, you could present key sociodemographic characteristics of the sample in a descriptive table.

Reviewer #2: Hand hygiene is a very important part of Personal Protective Equipment - however in the manuscript data on hand hygiene presence (I assume alcohol-based handrub)is presented combined with surface disinfectant - the two should be distinguished from each other since different use and process and this change should be reflected in the result section also

In results Table 2 - can you clarify if the sanitizer is hand sanitizer?

Can you identify any psychometric testing/ validation/piloting performed of the survey instruments? What about validation of the survey instrument answers? Was there a sample of completed forms that were validated?

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 Aug 12;16(8):e0255986. doi: 10.1371/journal.pone.0255986.r002

Author response to Decision Letter 0


23 Jun 2021

Dear reviewers,

Thank you for your valuable time and helpful comments on our manuscript. We have included a document entitled, "Response to Reviewers" with detailed information on how we addressed each of the comments.

Sincerely,

Arno Stöcker

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 1

Jianguo Wang

7 Jul 2021

PONE-D-21-13972R1

Stockpiled personal protective equipment and knowledge of pandemic plans as predictors of perceived pandemic preparedness among German general practitioners

PLOS ONE

Dear Dr. Stöcker,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

A minor revision is still required.

Please submit your revised manuscript by Aug 21 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Jianguo Wang, PhD

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Thank you for adequately addressing my suggested amendments to your manuscript.

I have just one more minor comment:

Limitations (page 21)

- Thank you for elaborating in detail about the limitations of an anonymous online survey, as well as the attempt to relate your sample's sociodemographic distribution to national demographic sources for German GPs. However, I would suggest that you cite the respective sources (e.g., Federal Register of Physicians, German Medical Association). Otherwise it is difficult for the reader to access and compare the relevant demographic characteristics accordingly.

Reviewer #2: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 Aug 12;16(8):e0255986. doi: 10.1371/journal.pone.0255986.r004

Author response to Decision Letter 1


24 Jul 2021

Dear Reviewers,

Thank you again for your valuable comment. Please find enclosed a revised version of our original research article for publication in PLoS ONE. We have included a document entitled, "Response to Reviewers" with detailed information on how we addressed your remaining comment.

Thank you for your time and effort.

Sincerely,

Arno Stöcker

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 2

Jianguo Wang

28 Jul 2021

Stockpiled personal protective equipment and knowledge of pandemic plans as predictors of perceived pandemic preparedness among German general practitioners

PONE-D-21-13972R2

Dear Dr. Stöcker,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Jianguo Wang, PhD

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: (No Response)

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Thank you for addressing my concerns. I have no further comments, and wish the authors all the best!

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Acceptance letter

Jianguo Wang

3 Aug 2021

PONE-D-21-13972R2

Stockpiled personal protective equipment and knowledge of pandemic plans as predictors of perceived pandemic preparedness among German general practitioners

Dear Dr. Stöcker:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Jianguo Wang

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Table. Questionnaire (German and English translation) questionnaire (German, original version).

    (DOCX)

    S2 Table. Key sociodemographic characteristics.

    (DOCX)

    Attachment

    Submitted filename: Response to Reviewers.docx

    Attachment

    Submitted filename: Response to Reviewers.docx

    Data Availability Statement

    The authors have uploaded a minimal data set to Data Archiving and Networked Services (DANS) which is available at https://doi.org/10.17026/dans-z7a-b6p9.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES